课题基金 / 基金详情

Cardioprotective Actions of Hydrogen Sulfide

Cardioprotective Actions of Hydrogen Sulfide
硫化氢的心脏保护作用
批准号:
8921357
负责人:
DAVID JOSEPH LEFER
金额:
$28.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-01-01 至 2016-12-31

项目摘要

项目成果

DAVID JOSEPH LEFER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hydrogen sulfide (H2S) has recently been identified as a physiologically important endogenous gaseous signaling molecule with a diverse array of biological activities. H2S is produced in micromolar quantities by two endogenous enzymes, cystathionine 3lyase (CGL) and cystathionine 2 synthase (CBS) and is critical for the maintenance of cardiovascular homeostasis. H2S attenuates leukocyte adhesion, modulates mitochondrial respiration, and inhibits both apoptosis, and oxidative stress. These physiological actions are ideal for the treatment of myocardial ischemia-reperfusion (MI-R) injury. Preliminary data clearly demonstrate that physiological levels of H2S significantly ameliorate MI-R injury and preserve left ventricular function. Preliminary data also indicate that H2S therapy triggers both "early" and "late" myocardial preconditioning. We also demonstrate that mice with cardiac-restricted CGL overexpression exhibit significantly increased myocardial H2S bioavailability and protection against myocardial I-R injury. The central hypothesis for the proposed studies is that H2S triggers a cardioprotective signaling cascade that confers robust cardioprotection in the setting of MI-R injury. The proposed studies will evaluate the various cardioprotective signals induced by H2S therapy during both "acute" and "chronic" pharmacological preconditioning as well as the during acute H2S therapy at the time of reperfusion. Specific Aim 1: To investigate the contribution of ATP sensitive K+ channels (KATP channels) in H2S- mediated cardioprotection against myocardial ischemia-reperfusion injury. In vitro studies will evaluate the effects of H2S on KATP channel activation and mitochondrial function. In vivo Studies will be performed using gene-targeted mice with cardiac myocyte deletion of KATP (Sur 1, Kir 6.1, and Kir 6.2 subunits) treated with H2S and subjected to MI-R. Specific Aim 2: To investigate the role of antioxidants in H2S-mediated cardioprotection. Studies will evaluate the acute and chronic effects of H2S on Nrf-2 activation and oxidative stress during MI-R. Studies will also investigate the effects of H2S on the induction of antioxidant signaling pathways in the myocardium prior to MI-R. Specific Aim 3: To investigate the role of the RISK pathway in H2S-mediated cardioprotection. Studies will investigate the effects of H2S on RISK pathway (PI3K, Akt, PKC5, and Erk 1/2) activation, downstream anti-apoptotic signaling, MPTP opening, and myocardial cell death following MI-R. The proposed studies will significantly extend our current understanding of the molecular and cellular pathophysiology of MI-R injury and provide the foundation for the development of H2S therapy for the treatment of acute myocardial infarction.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1161/circulationaha.116.027039
发表时间: 2017-07-04
期刊: Circulation
影响因子: 37.8
作者: [Lefer DJ, Marbán E]
通讯作者: Marbán E
DOI: 10.1586/ecp.10.56
发表时间: 2011-01
期刊: Expert review of clinical pharmacology
影响因子: 4.4
作者: [Predmore BL, Lefer DJ]
通讯作者: Lefer DJ
DOI: 10.1161/jaha.117.008268
发表时间: 2018-03-03
期刊: Journal of the American Heart Association
影响因子: 5.4
作者: [Trivedi RK, Polhemus DJ, Li Z, Yoo D, Koiwaya H, Scarborough A, Goodchild TT, Lefer DJ]
通讯作者: Lefer DJ
DOI: 10.1016/j.yjmcc.2013.08.002
发表时间: 2013-11
期刊: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
影响因子: 5
作者: [Nicholson, Chad K., Lambert, Jonathan P., Chow, Chi-Wing, Lefer, David J., Calvert, John W.]
通讯作者: Calvert, John W.
12
    Hydrogen Sulfide Regulation in Cardioprotection
    • 批准号:
      10391506
    • 项目类别:
    • 资助金额:
      $56.2万
    • 财政年份:
      2020
    • 负责人:
      DAVID JOSEPH LEFER
    • 依托单位:
    Hydrogen Sulfide Regulation in Cardioprotection
    • 批准号:
      10162413
    • 项目类别:
    • 资助金额:
      $57.6万
    • 财政年份:
      2020
    • 负责人:
      DAVID JOSEPH LEFER
    • 依托单位:
    Hydrogen Sulfide Regulation in Cardioprotection
    • 批准号:
      10610727
    • 项目类别:
    • 资助金额:
      $54.7万
    • 财政年份:
      2020
    • 负责人:
      DAVID JOSEPH LEFER
    • 依托单位:
    Endogenous Hydrogen Sulfide Enzymes in Heart Failure
    • 批准号:
      10077584
    • 项目类别:
    • 资助金额:
      $40.13万
    • 财政年份:
      2019
    • 负责人:
      DAVID JOSEPH LEFER
    • 依托单位:
    海外基金